JAZZ News and Press, Jazz Pharmaceuticals plc From 04/26/23

2023-04-26 10:00:43 ET For further details see: Zymeworks, Jazz in pact over cancer antibody zanidatamab

Jazz Pharmaceuticals to Present Advancements in Neuroscience at American Academy of Neurology Annual Meeting PR Newswire Eleven abstracts emphasize Jazz's leadership in neuroscience and commitment to advance understanding of sleep disorders, epilepsy and movement disorders ...

2023-04-13 05:02:47 ET A federal appeals court blocked part of a Texas court's ruling that would halt the access to the abortion pill mifepristone. Earlier this week, the U.S. Justice Department (DOJ) had asked the U.S. 5th Circuit Court of Appeals to halt U.S. Judge Matthew Kacsmar...

2023-04-11 08:30:43 ET Palm Beach, FL – April 11, 2023 – FinancialNewsMedia.com News Commentary –  The COVID-19 pandemic and associated social distancing norms and lockdown affected all industries globally. Although the COVID-19 pandemic negatively impa...

2023-04-10 10:48:10 ET A group of senior pharma executives, including Pfizer ( NYSE: PFE ) chief executive Albert Bourla, has come forward in support of the FDA after a Texas-based judge suspended the approval of abortion treatment mifepristone on Friday. Mifepristone, appro...

2023-04-09 11:00:57 ET Ancillary Cannabis Stocks April 2023 Are you looking for the best ways to invest in marijuana stocks for the short and long term? Recent declines in many top cannabis stocks have made them an interesting pay in 2023. One area that cannabis investors can look t...

Jazz Pharmaceuticals Expands Support of the American Heart Association to Raise Awareness of the Link Between Sleep Disorders and Heart Health PR Newswire Support to include dedicated educational website, science advisory panel, patient video...

2023-03-27 01:16:04 ET Summary This developing industry has ample opportunity and sustained tailwinds. Very few U.S. companies have positive operating margins; very few of their Canadian counterparts have positive gross margins. Since most of the ETFs are full of cash-burning ...

2023-03-21 11:18:17 ET Wells Fargo said that Zymeworks ( NASDAQ: ZYME ) is a buy citing the biotech's potential royalty streams and milestones from its lead oncology candidate. The firm has a $12 price target (~41% upside based on Monday's close). Derek Archila wrote t...

2023-03-21 06:45:00 ET A few years ago, the cannabis industry attracted much interest from investors following significant regulatory changes in Canada and anticipated progress elsewhere in developed countries. However, this interest has now died down, and many of the major companies in the...